Associated Papers
RNA m6A Methylation Promotes Tumor Development and WASF3 Translation in Esophageal Squamous Cell Carcinoma.
Shang QX et al.
Medcomm, 2025
41127505 (PubMed )
Supplement: MCO2-6-e70443-s001.docx
m6A modulates RAN translation from CAG repeat expansion RNA.
Sun Y et al.
Aggregate (hoboken, N.j.), 2025
Synonymous mutations promote tumorigenesis by disrupting m6A-dependent mRNA metabolism.
Lan Y et al.
Cell, 2025
m6A modification enhances the stability of CDC25A promotes tumorigenicity of esophagogastric junction adenocarcinoma via cell cycle.
Pan Y et al.
International Journal of Biological Sciences, 2024
The Mettl3 epitranscriptomic writer amplifies p53 stress responses.
Raj N et al.
Molecular Cell, 2022
METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding.
Wang W et al.
Nature Communications, 2021
34155197 (PubMed )
Supplement: 41467_2021_23501_MOESM1_ESM.pdf
mTORC1 promotes cell growth via m6A-dependent mRNA degradation.
Cho S et al.
Molecular Cell, 2021
METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome.
Shi W et al.
Frontiers in Cell and Developmental Biology, 2021
m6A Facilitates eIF4F-Independent mRNA Translation.
Coots RA et al.
Molecular Cell, 2017
m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways.
Li HB et al.
Nature, 2017
Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex.
Wang X et al.
Nature, 2016
Select a paper to view details